Literature DB >> 1404593

Interference is controlled by segment 2 and possibly by segment 8 of the nondefective interfering influenza virus variant A/FM/1/47-MA.

E G Brown1, C F Dimock, K Hannah.   

Abstract

On mouse adaption of A/FM/1/47, a variant, A/FM/1/47-MA (FM-MA), that had acquired the properties of increased virulence and interference was produced. Coinfection of cells with FM-MA and prototype strains of influenza virus yielded > 100-fold more FM-MA virus than prototype virus, whereas coinfection with the same prototype strains and the parental A/FM/1/47 virus produced equivalent yields, indicating that FM-MA had acquired mutations that confer the property of interference during mouse adaption. FM-MA is a nondefective interfering virus that grows to a high titer in vivo and in vitro. It has previously been shown that segments 4, 7, and 8 and possibly segment 5 account for the increased virulence. In this study we show by genetic analysis of FM-MA x A/HK/1/68 reassortants that segment 2, coding for the polymerase-associated protein PB1, and possibly segment 8, encoding the NS1 and NS2 proteins, control the ability of FM-MA to interfere. Interference could not be overcome by increasing the titer of the coinfecting strain, but delaying FM-MA infection by 4 to 6 h did avoid interference. During interference of A/HK/1/68, protein synthesis was inhibited by less than 65% throughout coinfection. Given the kinetics of interference and the small perturbation in protein synthesis, interference appeared to occur at the level of late genome replication or virus assembly. Virulence and interference in FM-MA were not linked. An interfering avirulent FM-MA x A/HK/1/68 reassortant, E07, was capable of protecting mice against lethal pneumonia due to a virulent noninterfering reassortant, H04.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1404593      PMCID: PMC240123     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  18 in total

1.  Viral interference-mediated selection of a plaque-type variant of influenza virus.

Authors:  L Noronha-Blob; I T Schulze
Journal:  Virology       Date:  1976-01       Impact factor: 3.616

2.  NS2 protein of influenza virus is found in purified virus and phosphorylated in infected cells.

Authors:  J C Richardson; R K Akkina
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

Review 3.  Functional inactivation of genes by dominant negative mutations.

Authors:  I Herskowitz
Journal:  Nature       Date:  1987 Sep 17-23       Impact factor: 49.962

4.  Increased virulence of a mouse-adapted variant of influenza A/FM/1/47 virus is controlled by mutations in genome segments 4, 5, 7, and 8.

Authors:  E G Brown
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 6.  Defective interfering viruses and infections of animals.

Authors:  A D Barrett; N J Dimmock
Journal:  Curr Top Microbiol Immunol       Date:  1986       Impact factor: 4.291

7.  Molecular model of a eucaryotic transcription complex: functions and movements of influenza P proteins during capped RNA-primed transcription.

Authors:  J Braam; I Ulmanen; R M Krug
Journal:  Cell       Date:  1983-09       Impact factor: 41.582

Review 8.  Origin and replication of defective interfering particles.

Authors:  J Perrault
Journal:  Curr Top Microbiol Immunol       Date:  1981       Impact factor: 4.291

9.  Influenza virus gene expression: control mechanisms at early and late times of infection and nuclear-cytoplasmic transport of virus-specific RNAs.

Authors:  G I Shapiro; T Gurney; R M Krug
Journal:  J Virol       Date:  1987-03       Impact factor: 5.103

10.  The genes associated with trans-dominance of the influenza A cold-adapted live virus vaccine.

Authors:  P Whitaker-Dowling; R Zvolenski; J S Youngner
Journal:  Virology       Date:  1991-01       Impact factor: 3.616

View more
  3 in total

1.  The influenza virus variant A/FM/1/47-MA possesses single amino acid replacements in the hemagglutinin, controlling virulence, and in the matrix protein, controlling virulence as well as growth.

Authors:  C A Smeenk; E G Brown
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

2.  Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant.

Authors:  R A Karron; D A Buonagurio; A F Georgiu; S S Whitehead; J E Adamus; M L Clements-Mann; D O Harris; V B Randolph; S A Udem; B R Murphy; M S Sidhu
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-09       Impact factor: 11.205

3.  Influenza A virus NS1 gene mutations F103L and M106I increase replication and virulence.

Authors:  Samar K Dankar; Shuai Wang; Jihui Ping; Nicole E Forbes; Liya Keleta; Yishan Li; Earl G Brown
Journal:  Virol J       Date:  2011-01-12       Impact factor: 4.099

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.